-
Eli Lilly and Company (LLY $1,057.89)
-
UnitedHealth Group Incorporated (DE) (UNH $323.21)
-
Harvest Healthcare Leaders Income ETF (HHL $7.75)
-
Harvest Healthcare Leaders Enhanced Income ETF (HHLE $9.36)
HHLE. This would increase my income by approximately 30% on this money and allow me to keep the same list of healthcare stocks. Does this make sense; any downsides ; am I missing anything?
As an aside , I am at breakeven with HHL as the sector is under pressure from Trump and also United Healthcare has dampened the sector. But with Trump wanting lower drug prices , the companies will be going overseas to compensate for lower US revenue as witnessed by Eli Lilly raising international prices for Mounjaro.
Thanks .Derek
HHLE is at the moment significantly smaller, but likely big enough at $70M, and we would expect it to grow. The main difference here is leverage. HHLE uses 25% leverage. This of course enhances returns but also can add to risk. We would be OK with a switch only on the condition that a risk-tolerant investor understands this use of leverage. The 'go outside the US' makes sense, but also US companies are starting to price in weak sentiment. It may take time, but there is still upside potential for the sector, and any good news might have an amplified positive impact since sentiment and valuations are so low.
Authors of this answer, directors, partners and/or officers of 5i Research and/or affiliated companies have a financial or other interest in UNH.